Qureight: Accelerating Drug Development with AI-Powered Imaging Analysis

Qureight is an AI company focused on advancing the understanding of lung and heart diseases, revolutionizing clinical trials, and accelerating drug development. By leveraging AI-powered data curation and collaborative analysis tools, Qureight serves biopharma, contract research organizations, and hospitals. Its platform integrates ML-based image algorithms, cloud-based medical imaging viewing, and AI-assisted workflows to streamline clinical trial processes and improve patient outcomes.

Key Features:

• AI-powered data curation for drug development
• Collaborative analysis of imaging, clinical data, and biomarkers
• ML-based image algorithms for CT scans and AI-assisted workflows
• Zero-footprint medical imaging viewing with cloud-based annotation and ML model runs
• Fast, AI-guided central read image workflows for clinical trials
• Access to a Key Opinion Leaders network
• AI-powered quantitative imaging analysis of CT scans
• ISO 13485 and ISO 27001 certification
• Compliance with GDPR, HIPAA, 21 CFR Part 11, and NHS Digital Toolkit
• Real-world data from global healthcare partners

Pricing:

Qureight offers a paid solution tailored for enterprise and healthcare organizations.

Conclusion:

Qureight is a transformative AI platform that empowers biopharma and healthcare institutions to enhance clinical trial efficiency and advance treatments for lung and heart diseases through cutting-edge technology and partnerships.